journal article·2023-12Open access

Anti‐Tumor Immunity Induced by a Ternary Membrane System Derived From Cancer Cells, Dendritic Cells, and Bacteria (Small 50/2023)

He Ren, Jiexin Li, Jingyu Zhang, Jingang Liu, Xingyue Yang, Nan Zhang, Qian Qiu, Dan Li, Yue Yu, Xiaofeng Liu, Jonathan F. Lovell, Yumiao Zhang

Small· Volume 19· Issue 50

Abstract

Anti-Tumor Immunity An “ABC” ternary membrane-derived nanosystem blended from antigen-presenting mature dendritic cell membranes (“A”), bacterial E. coli cytoplasmic membranes (“B”), and cancer cell membranes (“C”), shows great promise for use as a personalized tumor nanovaccine. ABC nanovaccine elicits immune responses on patient-derived dendritic cells (DCs) by homologous vaccines and promotes recovery from tumor in murine prophylactic and therapeutic models. More details can be found in article number 2302756 by Yumiao Zhang and co-workers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Innovative Microfluidic and Catalytic Techniques Innovation · Adenosine and Purinergic Signaling

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical Engineering and Technology Key Laboratory of Systems Bioengineering (Ministry of Education) Tianjin University Tianjin 300350 P. R. China

School of Life Science and Technology Weifang Medical University Shandong 261000 P. R. China

The First Department of Breast Cancer Tianjin Medical University Cancer Institute and Hospital Key Laboratory of Breast Cancer Prevention and Therapy Ministry of Education Key Laboratory of Cancer Prevention and Therapy National Clinical Research Center for Cancer Tianjin 300060 P. R. China

Department of Biomedical Engineering State University of New York at Buffalo Buffalo NY 14260 USA

References

Reference metadata was not supplied for this record.